{"organizations": [], "uuid": "e710c4eaa702a28ec3ce9935fa93647f141e29ad", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-innovate-biopharmaceuticals-expect/brief-innovate-biopharmaceuticals-expects-trading-under-new-ticker-to-begin-on-feb-1-idUSFWN1PQ0YY", "country": "US", "domain_rank": 408, "title": "BRIEF-Innovate Biopharmaceuticals Expects Trading Under New Ticker To Begin On Feb 1", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-31T14:39:00.000+02:00", "replies_count": 0, "uuid": "e710c4eaa702a28ec3ce9935fa93647f141e29ad"}, "author": "", "url": "https://www.reuters.com/article/brief-innovate-biopharmaceuticals-expect/brief-innovate-biopharmaceuticals-expects-trading-under-new-ticker-to-begin-on-feb-1-idUSFWN1PQ0YY", "ord_in_thread": 0, "title": "BRIEF-Innovate Biopharmaceuticals Expects Trading Under New Ticker To Begin On Feb 1", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters staff", "sentiment": "none"}, {"name": "innovate biopharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 31, 2018 / 12:39 PM / in 22 minutes BRIEF-Innovate Biopharmaceuticals Expects Trading Under New Ticker To Begin On Feb 1 Reuters Staff 1 Min Read \nJan 31 (Reuters) - Innovate Biopharmaceuticals Inc: \n* INNOVATE BIOPHARMACEUTICALS ANNOUNCES TRADING UNDER NEW TICKER SYMBOL INNT IS ANTICIPATED TO BEGIN ON THURSDAY, FEBRUARY 1, 2018 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-31T14:39:00.000+02:00", "crawled": "2018-01-31T15:08:05.006+02:00", "highlightTitle": ""}